Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC): An add-on project to “Duke University CMS Innovation Award Southeastern Diabetes Initiative”

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

This study leverages the existing research resources of a funded parent project “Duke University Centers for Medicare and Medicaid Services (CMS) Innovation Award Southeastern Diabetes initiative (PI: Robert M. Califf, MD).”  It explores the feasibility of implementing Screening for substance use, Brief Intervention, and Referral to Treatment services (SBIRT) in diabetic patients in primary care, and examines the effects of substance use status on diabetes health care outcomes.  It also assesses the feasibility of the CTN’s clinical decision support algorithm for SBIRT in the primary care setting.  This project uses a longitudinal, community-based design nested within the parent study in a diabetes care setting.  Adults aged 18 or older with type 2 diabetes and who meet the inclusion and exclusion criteria for the parent study at the Durham County, North Carolina sites will be screened and assessed for substance use at baseline and 6, 12, 18 and 24-month follow-up periods.  The study will examine changes in substance use trajectories and explore the impact of substance use status on subsequent diabetes care and health outcomes.

CTN Protocol ID: 
CTN-0057
ClinicalTrials.gov ID: 

Principal Investigator(s)

Li-Tzy Wu, Sc.D., R.N., M.A.
Professor
Department of Psychiatry and Behavioral Sciences
Duke University Medical Center
BOX 3903
Durham, NC 27710 
litzy.wu@duke.edu